Drugs / [F-18] fluorinated dihydrotestosterone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01724619 | Nov 2012 → Mar 2013 | prostate cancer | Wake Forest University Health Sciences | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [F-18] fluorinated dihydrotestosterone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01724619 ↗ |
| Known as | FDHT | “[F-18] fluorinated dihydrotestosterone (FDHT)” NCT01724619 ↗ |
| Modality | Diagnostic / imaging agent | “This study will test the utility of \[F-18\]FMDHT to image prostate cancer” NCT01724619 ↗ |